Daly David 4
4 · Singular Genomics Systems, Inc. · Filed Mar 8, 2022
Insider Transaction Report
Form 4
Daly David
President and Chief Operating
Transactions
- Award
Employee Stock Option (right to buy)
2022-03-04+125,000→ 0 totalExercise: $7.50Exp: 2032-03-04→ Common Stock (125,000 underlying) - Award
Employee Stock Option (right to buy)
2022-03-04+125,000→ 0 totalExercise: $7.50Exp: 2032-03-04→ Common Stock (125,000 underlying)
Footnotes (2)
- [F1]The option shares vest and become exercisable in 48 equal monthly installments measured from March 4, 2022.
- [F2]Subject to the achievement of certain performance targets by December 31, 2022, 25% of the option shares will vest and become exercisable on March 4, 2023, and the remaining option shares will vest and become exercisable in 36 equal monthly installments thereafter as the Reporting Person continues to provide services to the Issuer.